Skip to main content

Table 1 .

From: Estimation of potential cost-savings related to the implementation of perioperative hemodynamic goal-directed therapy

Actual morbidity rate no pGDT (%) 10 20 30 40 50 60
Expected morbidity rate pGDT (%) 3.5 to 5.5 7 to 11 11 to 17 14 to 22 18 to 28 21 to 33
Expected cost reduction/US patient ($) 808 to 1,167 1,615 to 2,333 2,423 to 3,500 3,231 to 4,667 4,039 to 5,833 4,846 to 7,000
Expected cost reduction/CH patient ($) 1,550 to 2,239 3,100 to 4,478 4,478 to 6,545 6,200 to 8,956 7,578 to 11,023 9,300 to 13,434